![Marc Struhalla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Struhalla
Chief Executive Officer at c-LEcta GmbH
Marc Struhalla active positions
Companies | Position | Start | End |
---|---|---|---|
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Chief Executive Officer | 2003-12-31 | - |
Founder | 2009-11-18 | - | |
Chief Operating Officer | 2003-12-31 | 2010-06-23 | |
Human Resources Officer | 2003-12-31 | 2010-06-23 | |
General Counsel | 2003-12-31 | 2010-06-23 |
Career history of Marc Struhalla
Training of Marc Struhalla
Universität Leipzig | Undergraduate Degree |
University of Hamburg | Doctorate Degree |
Statistics
International
Germany | 4 |
Operational
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Founder | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Health Technology |
- Stock Market
- Insiders
- Marc Struhalla
- Experience